What Types of Cancer Are Treated with PARP Inhibitors?
PARP inhibitors are primarily used in treating ovarian, breast, pancreatic, and prostate cancers, especially in patients with BRCA1 or BRCA2 mutations. These drugs show significant efficacy in patients who have inherited or acquired defects in these genes, as their cancer cells are more reliant on PARP for DNA repair.
